215 related articles for article (PubMed ID: 2856877)
1. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
2. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
3. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
4. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
Clements D; Elias E
Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
[No Abstract] [Full Text] [Related]
5. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
7. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
Christensen C
Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
[TBL] [Abstract][Full Text] [Related]
8. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
9. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and analogues in the treatment of VIPoma.
O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
[No Abstract] [Full Text] [Related]
11. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
Santangelo WC; Dueno MI; Krejs GJ
Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
[No Abstract] [Full Text] [Related]
12. Metastatic vipoma arising from colonic primary tumour.
Bradley C; Haddock G; Pickard RG; Rankin EM
Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
[TBL] [Abstract][Full Text] [Related]
13. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
[No Abstract] [Full Text] [Related]
14. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
Christensen C
Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
[TBL] [Abstract][Full Text] [Related]
16. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
17. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
18. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
[TBL] [Abstract][Full Text] [Related]
19. Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
Fennelly JJ; Cantwell B; Fielding JF; FitzGerald O; Collins PG; Buchanan KD
Clin Oncol; 1982 Jun; 8(2):167-70. PubMed ID: 6286202
[No Abstract] [Full Text] [Related]
20. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours.
Lamberts SW; Pieters GF; Metselaar HJ; Ong GL; Tan HS; Reubi JC
Acta Endocrinol (Copenh); 1988 Dec; 119(4):561-6. PubMed ID: 2849276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]